Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Canada Cannabis fees rise in line with inflation…
  • Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
  • Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
  • Spain Podemos and allies call for hemp regulation…
  • Belgium Positive notifications list updated…
  • Bulgaria Industrial cannabis THC limit could be increased…
  • Germany Public hearing held over decriminalising cannabis…
  • Afghanistan Decree issued to ban hemp cultivation…
  • United States Bills on hemp and CBD regulatory framework reintroduced in the House…
  • Maryland - United States Bill updating definition of hemp and hemp product passes Senate…
  • Kentucky - United States Medical cannabis bill passes Senate and head to House…
  • Luxembourg Council of State issues opinion over cannabis legislation…
View all
News analysis

Actor refutes claims he endorsed CBD products: business news in brief

Written by || 18th February 2020 || News analysis | Companies | Health and science | Technology and innovation | Asia Australasia Australia Belgium Brazil California Canada Colorado Delaware Europe Israel Nevada New York North America South America Texas United States Vermont Virginia Wyoming

Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
Sports Illustrated to promote CBD products: business news in brief
Regulatory report: CBD and hemp products – EU trademarks and patents
CBD-Intel regulatory news in brief, 28th January-3rd February

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.